Dyne Therapeutics grants new-hire equity awards for 212,500 shares under inducement plan
DYN•Inducement equity awards for newly hired employees
Dyne Therapeutics granted inducement equity awards to 11 newly hired employees under its 2024 Inducement Stock Incentive Plan.
The awards include non-statutory stock options covering 161,300 shares, priced at the Aug. 19 Nasdaq closing price, with a 10-year term.
The options vest over four years, starting with 25% on the first anniversary of each employee’s start date.
Restricted stock units cover 51,200 shares, vesting in four equal annual installments over four years from each start date.
